0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Prescription Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-31K9957
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Prescription Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Prescription Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31K9957
Report
October 2024
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prescription Medicine - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prescription Medicine - Market

Prescription Medicine - Market

The global market for Prescription Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prescription Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prescription Medicine by region & country, by Type, and by Application.
The Prescription Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Medicine.
Market Segmentation

Scope of Prescription Medicine - Market Report

Report Metric Details
Report Name Prescription Medicine - Market
CAGR 5%
Segment by Type:
  • Original Brand Drug
  • Generic Drug
Segment by Application
  • Hospital
  • Clinic
  • Online
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, Astellas Pharma, Biogen, CSL, Daiichi Sankyo, Otsuka Holdings, UCB, LES LABORATOIRES SERVIER, Bausch Health Companies, Eisai, Abbott Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Prescription Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Prescription Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Prescription Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Prescription Medicine - Market report?

Ans: The main players in the Prescription Medicine - Market are Pfizer, Roche, Novartis, Johnson & Johnson, Merck & Co., Sanofi, AbbVie, GlaxoSmithKline, Amgen, Gilead Science, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Bayer, Novo Nordisk, Takeda, Boehringer-Ingelheim, Allergan, Teva Pharmaceutical Industries, Mylan, Astellas Pharma, Biogen, CSL, Daiichi Sankyo, Otsuka Holdings, UCB, LES LABORATOIRES SERVIER, Bausch Health Companies, Eisai, Abbott Laboratories

What are the Application segmentation covered in the Prescription Medicine - Market report?

Ans: The Applications covered in the Prescription Medicine - Market report are Hospital, Clinic, Online, Others

What are the Type segmentation covered in the Prescription Medicine - Market report?

Ans: The Types covered in the Prescription Medicine - Market report are Original Brand Drug, Generic Drug

1 Market Overview
1.1 Prescription Medicine Product Introduction
1.2 Global Prescription Medicine Market Size Forecast
1.3 Prescription Medicine Market Trends & Drivers
1.3.1 Prescription Medicine Industry Trends
1.3.2 Prescription Medicine Market Drivers & Opportunity
1.3.3 Prescription Medicine Market Challenges
1.3.4 Prescription Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prescription Medicine Players Revenue Ranking (2023)
2.2 Global Prescription Medicine Revenue by Company (2019-2024)
2.3 Key Companies Prescription Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Prescription Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Prescription Medicine
2.6 Prescription Medicine Market Competitive Analysis
2.6.1 Prescription Medicine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Prescription Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Original Brand Drug
3.1.2 Generic Drug
3.2 Global Prescription Medicine Sales Value by Type
3.2.1 Global Prescription Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prescription Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Prescription Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Online
4.1.4 Others
4.2 Global Prescription Medicine Sales Value by Application
4.2.1 Global Prescription Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prescription Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Prescription Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Prescription Medicine Sales Value by Region
5.1.1 Global Prescription Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prescription Medicine Sales Value by Region (2019-2024)
5.1.3 Global Prescription Medicine Sales Value by Region (2025-2030)
5.1.4 Global Prescription Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Prescription Medicine Sales Value, 2019-2030
5.2.2 North America Prescription Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Prescription Medicine Sales Value, 2019-2030
5.3.2 Europe Prescription Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Prescription Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Prescription Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Prescription Medicine Sales Value, 2019-2030
5.5.2 South America Prescription Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prescription Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Prescription Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prescription Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prescription Medicine Sales Value
6.3 United States
6.3.1 United States Prescription Medicine Sales Value, 2019-2030
6.3.2 United States Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prescription Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prescription Medicine Sales Value, 2019-2030
6.4.2 Europe Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prescription Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prescription Medicine Sales Value, 2019-2030
6.5.2 China Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prescription Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prescription Medicine Sales Value, 2019-2030
6.6.2 Japan Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prescription Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prescription Medicine Sales Value, 2019-2030
6.7.2 South Korea Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prescription Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prescription Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prescription Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prescription Medicine Sales Value, 2019-2030
6.9.2 India Prescription Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prescription Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Prescription Medicine Products, Services and Solutions
7.1.4 Pfizer Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche Prescription Medicine Products, Services and Solutions
7.2.4 Roche Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Recent Developments
7.3 Novartis
7.3.1 Novartis Profile
7.3.2 Novartis Main Business
7.3.3 Novartis Prescription Medicine Products, Services and Solutions
7.3.4 Novartis Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson & Johnson Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Profile
7.4.2 Johnson & Johnson Main Business
7.4.3 Johnson & Johnson Prescription Medicine Products, Services and Solutions
7.4.4 Johnson & Johnson Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson & Johnson Recent Developments
7.5 Merck & Co.
7.5.1 Merck & Co. Profile
7.5.2 Merck & Co. Main Business
7.5.3 Merck & Co. Prescription Medicine Products, Services and Solutions
7.5.4 Merck & Co. Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Merck & Co. Recent Developments
7.6 Sanofi
7.6.1 Sanofi Profile
7.6.2 Sanofi Main Business
7.6.3 Sanofi Prescription Medicine Products, Services and Solutions
7.6.4 Sanofi Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 Sanofi Recent Developments
7.7 AbbVie
7.7.1 AbbVie Profile
7.7.2 AbbVie Main Business
7.7.3 AbbVie Prescription Medicine Products, Services and Solutions
7.7.4 AbbVie Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 AbbVie Recent Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Profile
7.8.2 GlaxoSmithKline Main Business
7.8.3 GlaxoSmithKline Prescription Medicine Products, Services and Solutions
7.8.4 GlaxoSmithKline Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Recent Developments
7.9 Amgen
7.9.1 Amgen Profile
7.9.2 Amgen Main Business
7.9.3 Amgen Prescription Medicine Products, Services and Solutions
7.9.4 Amgen Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.9.5 Amgen Recent Developments
7.10 Gilead Science
7.10.1 Gilead Science Profile
7.10.2 Gilead Science Main Business
7.10.3 Gilead Science Prescription Medicine Products, Services and Solutions
7.10.4 Gilead Science Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.10.5 Gilead Science Recent Developments
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Profile
7.11.2 Bristol-Myers Squibb Main Business
7.11.3 Bristol-Myers Squibb Prescription Medicine Products, Services and Solutions
7.11.4 Bristol-Myers Squibb Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.11.5 Bristol-Myers Squibb Recent Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Profile
7.12.2 AstraZeneca Main Business
7.12.3 AstraZeneca Prescription Medicine Products, Services and Solutions
7.12.4 AstraZeneca Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.12.5 AstraZeneca Recent Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Profile
7.13.2 Eli Lilly Main Business
7.13.3 Eli Lilly Prescription Medicine Products, Services and Solutions
7.13.4 Eli Lilly Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.13.5 Eli Lilly Recent Developments
7.14 Bayer
7.14.1 Bayer Profile
7.14.2 Bayer Main Business
7.14.3 Bayer Prescription Medicine Products, Services and Solutions
7.14.4 Bayer Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.14.5 Bayer Recent Developments
7.15 Novo Nordisk
7.15.1 Novo Nordisk Profile
7.15.2 Novo Nordisk Main Business
7.15.3 Novo Nordisk Prescription Medicine Products, Services and Solutions
7.15.4 Novo Nordisk Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.15.5 Novo Nordisk Recent Developments
7.16 Takeda
7.16.1 Takeda Profile
7.16.2 Takeda Main Business
7.16.3 Takeda Prescription Medicine Products, Services and Solutions
7.16.4 Takeda Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.16.5 Takeda Recent Developments
7.17 Boehringer-Ingelheim
7.17.1 Boehringer-Ingelheim Profile
7.17.2 Boehringer-Ingelheim Main Business
7.17.3 Boehringer-Ingelheim Prescription Medicine Products, Services and Solutions
7.17.4 Boehringer-Ingelheim Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.17.5 Boehringer-Ingelheim Recent Developments
7.18 Allergan
7.18.1 Allergan Profile
7.18.2 Allergan Main Business
7.18.3 Allergan Prescription Medicine Products, Services and Solutions
7.18.4 Allergan Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.18.5 Allergan Recent Developments
7.19 Teva Pharmaceutical Industries
7.19.1 Teva Pharmaceutical Industries Profile
7.19.2 Teva Pharmaceutical Industries Main Business
7.19.3 Teva Pharmaceutical Industries Prescription Medicine Products, Services and Solutions
7.19.4 Teva Pharmaceutical Industries Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.19.5 Teva Pharmaceutical Industries Recent Developments
7.20 Mylan
7.20.1 Mylan Profile
7.20.2 Mylan Main Business
7.20.3 Mylan Prescription Medicine Products, Services and Solutions
7.20.4 Mylan Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.20.5 Mylan Recent Developments
7.21 Astellas Pharma
7.21.1 Astellas Pharma Profile
7.21.2 Astellas Pharma Main Business
7.21.3 Astellas Pharma Prescription Medicine Products, Services and Solutions
7.21.4 Astellas Pharma Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.21.5 Astellas Pharma Recent Developments
7.22 Biogen
7.22.1 Biogen Profile
7.22.2 Biogen Main Business
7.22.3 Biogen Prescription Medicine Products, Services and Solutions
7.22.4 Biogen Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.22.5 Biogen Recent Developments
7.23 CSL
7.23.1 CSL Profile
7.23.2 CSL Main Business
7.23.3 CSL Prescription Medicine Products, Services and Solutions
7.23.4 CSL Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.23.5 CSL Recent Developments
7.24 Daiichi Sankyo
7.24.1 Daiichi Sankyo Profile
7.24.2 Daiichi Sankyo Main Business
7.24.3 Daiichi Sankyo Prescription Medicine Products, Services and Solutions
7.24.4 Daiichi Sankyo Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.24.5 Daiichi Sankyo Recent Developments
7.25 Otsuka Holdings
7.25.1 Otsuka Holdings Profile
7.25.2 Otsuka Holdings Main Business
7.25.3 Otsuka Holdings Prescription Medicine Products, Services and Solutions
7.25.4 Otsuka Holdings Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.25.5 Otsuka Holdings Recent Developments
7.26 UCB
7.26.1 UCB Profile
7.26.2 UCB Main Business
7.26.3 UCB Prescription Medicine Products, Services and Solutions
7.26.4 UCB Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.26.5 UCB Recent Developments
7.27 LES LABORATOIRES SERVIER
7.27.1 LES LABORATOIRES SERVIER Profile
7.27.2 LES LABORATOIRES SERVIER Main Business
7.27.3 LES LABORATOIRES SERVIER Prescription Medicine Products, Services and Solutions
7.27.4 LES LABORATOIRES SERVIER Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.27.5 LES LABORATOIRES SERVIER Recent Developments
7.28 Bausch Health Companies
7.28.1 Bausch Health Companies Profile
7.28.2 Bausch Health Companies Main Business
7.28.3 Bausch Health Companies Prescription Medicine Products, Services and Solutions
7.28.4 Bausch Health Companies Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.28.5 Bausch Health Companies Recent Developments
7.29 Eisai
7.29.1 Eisai Profile
7.29.2 Eisai Main Business
7.29.3 Eisai Prescription Medicine Products, Services and Solutions
7.29.4 Eisai Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.29.5 Eisai Recent Developments
7.30 Abbott Laboratories
7.30.1 Abbott Laboratories Profile
7.30.2 Abbott Laboratories Main Business
7.30.3 Abbott Laboratories Prescription Medicine Products, Services and Solutions
7.30.4 Abbott Laboratories Prescription Medicine Revenue (US$ Million) & (2019-2024)
7.30.5 Abbott Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Prescription Medicine Industrial Chain
8.2 Prescription Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prescription Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Prescription Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Prescription Medicine Market Trends
    Table 2. Prescription Medicine Market Drivers & Opportunity
    Table 3. Prescription Medicine Market Challenges
    Table 4. Prescription Medicine Market Restraints
    Table 5. Global Prescription Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Prescription Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Prescription Medicine Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Prescription Medicine Product Type
    Table 9. Key Companies Time to Begin Mass Production of Prescription Medicine
    Table 10. Global Prescription Medicine Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Prescription Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Prescription Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Prescription Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Prescription Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Prescription Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Prescription Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Prescription Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Prescription Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Prescription Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Prescription Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Prescription Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Prescription Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Prescription Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Prescription Medicine Sales Value by Region (2019-2024) & (%)
    Table 27. Global Prescription Medicine Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Prescription Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Prescription Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Prescription Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Prescription Medicine Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Prescription Medicine Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. Roche Basic Information List
    Table 37. Roche Description and Business Overview
    Table 38. Roche Prescription Medicine Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Prescription Medicine Business of Roche (2019-2024)
    Table 40. Roche Recent Developments
    Table 41. Novartis Basic Information List
    Table 42. Novartis Description and Business Overview
    Table 43. Novartis Prescription Medicine Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Prescription Medicine Business of Novartis (2019-2024)
    Table 45. Novartis Recent Developments
    Table 46. Johnson & Johnson Basic Information List
    Table 47. Johnson & Johnson Description and Business Overview
    Table 48. Johnson & Johnson Prescription Medicine Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Prescription Medicine Business of Johnson & Johnson (2019-2024)
    Table 50. Johnson & Johnson Recent Developments
    Table 51. Merck & Co. Basic Information List
    Table 52. Merck & Co. Description and Business Overview
    Table 53. Merck & Co. Prescription Medicine Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Prescription Medicine Business of Merck & Co. (2019-2024)
    Table 55. Merck & Co. Recent Developments
    Table 56. Sanofi Basic Information List
    Table 57. Sanofi Description and Business Overview
    Table 58. Sanofi Prescription Medicine Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Prescription Medicine Business of Sanofi (2019-2024)
    Table 60. Sanofi Recent Developments
    Table 61. AbbVie Basic Information List
    Table 62. AbbVie Description and Business Overview
    Table 63. AbbVie Prescription Medicine Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Prescription Medicine Business of AbbVie (2019-2024)
    Table 65. AbbVie Recent Developments
    Table 66. GlaxoSmithKline Basic Information List
    Table 67. GlaxoSmithKline Description and Business Overview
    Table 68. GlaxoSmithKline Prescription Medicine Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Prescription Medicine Business of GlaxoSmithKline (2019-2024)
    Table 70. GlaxoSmithKline Recent Developments
    Table 71. Amgen Basic Information List
    Table 72. Amgen Description and Business Overview
    Table 73. Amgen Prescription Medicine Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Prescription Medicine Business of Amgen (2019-2024)
    Table 75. Amgen Recent Developments
    Table 76. Gilead Science Basic Information List
    Table 77. Gilead Science Description and Business Overview
    Table 78. Gilead Science Prescription Medicine Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Prescription Medicine Business of Gilead Science (2019-2024)
    Table 80. Gilead Science Recent Developments
    Table 81. Bristol-Myers Squibb Basic Information List
    Table 82. Bristol-Myers Squibb Description and Business Overview
    Table 83. Bristol-Myers Squibb Prescription Medicine Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Prescription Medicine Business of Bristol-Myers Squibb (2019-2024)
    Table 85. Bristol-Myers Squibb Recent Developments
    Table 86. AstraZeneca Basic Information List
    Table 87. AstraZeneca Description and Business Overview
    Table 88. AstraZeneca Prescription Medicine Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Prescription Medicine Business of AstraZeneca (2019-2024)
    Table 90. AstraZeneca Recent Developments
    Table 91. Eli Lilly Basic Information List
    Table 92. Eli Lilly Description and Business Overview
    Table 93. Eli Lilly Prescription Medicine Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Prescription Medicine Business of Eli Lilly (2019-2024)
    Table 95. Eli Lilly Recent Developments
    Table 96. Bayer Basic Information List
    Table 97. Bayer Description and Business Overview
    Table 98. Bayer Prescription Medicine Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Prescription Medicine Business of Bayer (2019-2024)
    Table 100. Bayer Recent Developments
    Table 101. Novo Nordisk Basic Information List
    Table 102. Novo Nordisk Description and Business Overview
    Table 103. Novo Nordisk Prescription Medicine Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Prescription Medicine Business of Novo Nordisk (2019-2024)
    Table 105. Novo Nordisk Recent Developments
    Table 106. Takeda Basic Information List
    Table 107. Takeda Description and Business Overview
    Table 108. Takeda Prescription Medicine Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Prescription Medicine Business of Takeda (2019-2024)
    Table 110. Takeda Recent Developments
    Table 111. Boehringer-Ingelheim Basic Information List
    Table 112. Boehringer-Ingelheim Description and Business Overview
    Table 113. Boehringer-Ingelheim Prescription Medicine Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Prescription Medicine Business of Boehringer-Ingelheim (2019-2024)
    Table 115. Boehringer-Ingelheim Recent Developments
    Table 116. Allergan Basic Information List
    Table 117. Allergan Description and Business Overview
    Table 118. Allergan Prescription Medicine Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Prescription Medicine Business of Allergan (2019-2024)
    Table 120. Allergan Recent Developments
    Table 121. Teva Pharmaceutical Industries Basic Information List
    Table 122. Teva Pharmaceutical Industries Description and Business Overview
    Table 123. Teva Pharmaceutical Industries Prescription Medicine Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Prescription Medicine Business of Teva Pharmaceutical Industries (2019-2024)
    Table 125. Teva Pharmaceutical Industries Recent Developments
    Table 126. Mylan Basic Information List
    Table 127. Mylan Description and Business Overview
    Table 128. Mylan Prescription Medicine Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Prescription Medicine Business of Mylan (2019-2024)
    Table 130. Mylan Recent Developments
    Table 131. Astellas Pharma Basic Information List
    Table 132. Astellas Pharma Description and Business Overview
    Table 133. Astellas Pharma Prescription Medicine Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Prescription Medicine Business of Astellas Pharma (2019-2024)
    Table 135. Astellas Pharma Recent Developments
    Table 136. Biogen Basic Information List
    Table 137. Biogen Description and Business Overview
    Table 138. Biogen Prescription Medicine Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Prescription Medicine Business of Biogen (2019-2024)
    Table 140. Biogen Recent Developments
    Table 141. CSL Basic Information List
    Table 142. CSL Description and Business Overview
    Table 143. CSL Prescription Medicine Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Prescription Medicine Business of CSL (2019-2024)
    Table 145. CSL Recent Developments
    Table 146. Daiichi Sankyo Basic Information List
    Table 147. Daiichi Sankyo Description and Business Overview
    Table 148. Daiichi Sankyo Prescription Medicine Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Prescription Medicine Business of Daiichi Sankyo (2019-2024)
    Table 150. Daiichi Sankyo Recent Developments
    Table 151. Otsuka Holdings Basic Information List
    Table 152. Otsuka Holdings Description and Business Overview
    Table 153. Otsuka Holdings Prescription Medicine Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Prescription Medicine Business of Otsuka Holdings (2019-2024)
    Table 155. Otsuka Holdings Recent Developments
    Table 156. UCB Basic Information List
    Table 157. UCB Description and Business Overview
    Table 158. UCB Prescription Medicine Products, Services and Solutions
    Table 159. Revenue (US$ Million) in Prescription Medicine Business of UCB (2019-2024)
    Table 160. UCB Recent Developments
    Table 161. LES LABORATOIRES SERVIER Basic Information List
    Table 162. LES LABORATOIRES SERVIER Description and Business Overview
    Table 163. LES LABORATOIRES SERVIER Prescription Medicine Products, Services and Solutions
    Table 164. Revenue (US$ Million) in Prescription Medicine Business of LES LABORATOIRES SERVIER (2019-2024)
    Table 165. LES LABORATOIRES SERVIER Recent Developments
    Table 166. Bausch Health Companies Basic Information List
    Table 167. Bausch Health Companies Description and Business Overview
    Table 168. Bausch Health Companies Prescription Medicine Products, Services and Solutions
    Table 169. Revenue (US$ Million) in Prescription Medicine Business of Bausch Health Companies (2019-2024)
    Table 170. Bausch Health Companies Recent Developments
    Table 171. Eisai Basic Information List
    Table 172. Eisai Description and Business Overview
    Table 173. Eisai Prescription Medicine Products, Services and Solutions
    Table 174. Revenue (US$ Million) in Prescription Medicine Business of Eisai (2019-2024)
    Table 175. Eisai Recent Developments
    Table 176. Abbott Laboratories Basic Information List
    Table 177. Abbott Laboratories Description and Business Overview
    Table 178. Abbott Laboratories Prescription Medicine Products, Services and Solutions
    Table 179. Revenue (US$ Million) in Prescription Medicine Business of Abbott Laboratories (2019-2024)
    Table 180. Abbott Laboratories Recent Developments
    Table 181. Key Raw Materials Lists
    Table 182. Raw Materials Key Suppliers Lists
    Table 183. Prescription Medicine Downstream Customers
    Table 184. Prescription Medicine Distributors List
    Table 185. Research Programs/Design for This Report
    Table 186. Key Data Information from Secondary Sources
    Table 187. Key Data Information from Primary Sources
    Table 188. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Prescription Medicine Product Picture
    Figure 2. Global Prescription Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Prescription Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Prescription Medicine Report Years Considered
    Figure 5. Global Prescription Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prescription Medicine Revenue in 2023
    Figure 7. Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Original Brand Drug Picture
    Figure 9. Generic Drug Picture
    Figure 10. Global Prescription Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Prescription Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Online
    Figure 15. Product Picture of Others
    Figure 16. Global Prescription Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Prescription Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Prescription Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Prescription Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Prescription Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Prescription Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Prescription Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Prescription Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Prescription Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Prescription Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Prescription Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Prescription Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Prescription Medicine Sales Value (%), (2019-2030)
    Figure 29. United States Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Prescription Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Prescription Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Prescription Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 50. Prescription Medicine Industrial Chain
    Figure 51. Prescription Medicine Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T19555
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30T17927
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18L19449
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Add to Cart